139 related articles for article (PubMed ID: 28187036)
1. A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma.
Singh V; Manalang M; Singh M; Apte U
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):654-657. PubMed ID: 28187036
[TBL] [Abstract][Full Text] [Related]
2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
4. Cytomorphology of hepatoblastoma with histological correlation and role of SALL4 immunocytochemistry in its diagnosis, subtyping, and prognostication.
Nakra T; Roy M; Yadav R; Agarwala S; Jassim M; Khanna G; Das P; Jain D; Mathur SR; Iyer VK
Cancer Cytopathol; 2020 Mar; 128(3):190-200. PubMed ID: 31880869
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of survivin in hepatoblastoma after chemotherapy.
Uehara S; Oue T; Kawatsu M; Nara K; Fukuzawa M
Eur J Pediatr Surg; 2013 Oct; 23(5):400-4. PubMed ID: 23444076
[TBL] [Abstract][Full Text] [Related]
6. Expression of RECK and MMPs in Hepatoblastoma and Neuroblastoma and Comparative Analysis on the Tumor Metastasis.
Xu M; Wang HF; Zhang HZ
Asian Pac J Cancer Prev; 2015; 16(9):4007-11. PubMed ID: 25987077
[TBL] [Abstract][Full Text] [Related]
7. Hepatic progenitor cells in liver cancers from Asian children.
Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
[TBL] [Abstract][Full Text] [Related]
8. Activated NOTCH2 is overexpressed in hepatoblastomas: an immunohistochemical study.
Litten JB; Chen TT; Schultz R; Herman K; Comstock J; Schiffman J; Tomlinson GE; Rakheja D
Pediatr Dev Pathol; 2011; 14(5):378-83. PubMed ID: 21639801
[TBL] [Abstract][Full Text] [Related]
9. Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology.
Rugge M; Sonego F; Pollice L; Perilongo G; Guido M; Basso G; Ninfo V; Pennelli N; Gambini C; Guglielmi M; Fabiano A; Leandro G; Keeling JW
Liver; 1998 Apr; 18(2):128-33. PubMed ID: 9588772
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
12. beta-Catenin and met deregulation in childhood Hepatoblastomas.
Ranganathan S; Tan X; Monga SP
Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454
[TBL] [Abstract][Full Text] [Related]
13. Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.
Bera G; Das RN; Roy P; Ghosh R; Islam N; Mishra PK; Chatterjee U
Pediatr Surg Int; 2017 Sep; 33(9):961-970. PubMed ID: 28631020
[TBL] [Abstract][Full Text] [Related]
14. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
Zhou S; Parham DM; Yung E; Pattengale P; Wang L
Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
[TBL] [Abstract][Full Text] [Related]
15. Multifocal hepatic neoplasia in 3 children with APC gene mutation.
Gupta A; Sheridan RM; Towbin A; Geller JI; Tiao G; Bove KE
Am J Surg Pathol; 2013 Jul; 37(7):1058-66. PubMed ID: 23715166
[TBL] [Abstract][Full Text] [Related]
16. POST-TEXT III and IV Hepatoblastoma: Extended Hepatic Resection Avoids Liver Transplantation in Selected Cases.
Fuchs J; Cavdar S; Blumenstock G; Ebinger M; Schäfer JF; Sipos B; Warmann SW
Ann Surg; 2017 Aug; 266(2):318-323. PubMed ID: 27501172
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.
Ara T; Fukuzawa M; Oue T; Komoto Y; Kusafuka T; Imura K; Okada A
J Pediatr Surg; 1997 Dec; 32(12):1690-4. PubMed ID: 9434000
[TBL] [Abstract][Full Text] [Related]
18. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression predicts metachronous pulmonary metastasis and poor survival in patients with hepatoblastoma.
Tsukada M; Wakai T; Matsuda Y; Korita PV; Shirai Y; Ajioka Y; Hatakeyama K; Kubota M
J Pediatr Surg; 2009 Aug; 44(8):1522-8. PubMed ID: 19635299
[TBL] [Abstract][Full Text] [Related]
19. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
[TBL] [Abstract][Full Text] [Related]
20. Expression of glypican-3 is highly associated with pediatric hepatoblastoma: a systemic analysis.
Xiong XL; Qin H; Yan SQ; Zhou LS; Chen P; Zhao D
Asian Pac J Cancer Prev; 2015; 16(3):1029-31. PubMed ID: 25735325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
